Hemostasis Diagnostics Market
Overview:
Hemostasis diagnostics is used for detecting defects that are responsible for excessive bleeding. Hemostatis slows down and stops the blood flow to start the healing of a wound after a vascular injury. The body uses this procedures as a first line of action. In the process of hemostatis, the blood transforms to the gelatinous state from the fluid state. Three mechanisms namely vasoconstriction, platelet plug formation, and blood coagulation maintains hemostatis in the body. According to a research, the proper therapy for treating haemorrhage is administered of fresh frozen plasma for coagulation defects, antifibrinolytic agents for systemic fibrinolysis, or Von Willebrand factor concentrates for defects of platelet function defects.
To Get Research PDF Brochure Here @ https://www.coherentmarketinsights.com/insight/request-pdf/434
Market Taxonomy:
The global hemostasis diagnostics market is divided by product type, technology, end user and geography.
By Product Type:
- Instruments
- By Type
- Analyzers
- Coagulation instrument
- Other instruments
- By Technology
- Automated
- Semi-Automated
- Manual
- Reagents & Kits
By Test Type:
- Prothrombin Test Time (PT)
- Fibrinogen Degradation Products (FDP)
- Activated Partial Thromboplastin Time (APTT)
- Activated Clotting Time, Platelet Aggregation Test
- D Dimer
By End User:
- Independent Diagnostic
- Hospital/Clinics
- Laboratories
By Region
- North America
- Europe
- Latin America
- Middle East
- Asia Pacific
- Africa
๐๐ก๐ซ๐ข๐ฌ๐ญ๐ฆ๐๐ฌ ๐๐๐ฅ๐ ๐๐ฌ ๐๐ข๐ฏ๐!
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐จ ๐๐ฏ๐๐ข๐ฅ ๐๐ข๐ฌ๐๐จ๐ฎ๐ง๐ญ ๐ ๐ซ๐จ๐ฆ ๐๐-๐๐% ๐ญ๐ข๐ฅ๐ฅ ๐๐-๐๐๐-๐๐๐๐
Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/434
Drivers:
Increasing cases of genetic disorders such as haemophilia, growing number of surgical procedures and trauma patients, and the rise in adoption of recombinant products are the factors expected to propel growth of the global hemostasis diagnostics market during the forecast period. For instance, in 2012, the National Hemophilia Foundation estimated that around 400,000 people are affected by hemophilia globally.
Moreover, other factors that are expected to boost growth of the market include biodegradable and affordable products, monoclonal antibodies, chromogenic substrates, technological development in molecular diagnostics, immunoassays, and laboratory automations.
Regional Analysis:
The global hemostasis diagnostic market is regionally divided into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa.
Among regions, North America is expected to witness significant growth in the global hemostasis diagnostics market during the forecast period due to increase in installed instruments driving increased reagents sales and support services, and higher number of haemophilia cases in the region. For instance, in 2015, as per the Centre for Disease Control and Prevention (CDC), the cases of hemophilia are expected to be 20,000 in the U.S.
Furthermore, Europe is expected to witness strong growth in the market due to rising hemostasis cases in the region. For instance, in 2017, the European National Registry of Congenital Coagulopathies the cases of hemostatis increases to around 11,000 in 2015 from 7000 in 2000.
Moreover, Asia Pacific is also expected to witness robust growth in the global hemostasis diagnostics market during the forecast period, owing to increasing healthcare expenditure, advancing technological capabilities, economic development, and high affordability.
Major Players:
Major players active in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc. Alere, Inc., Beckman Coulter Inc. Sekisui, Chrono-Log, HORIBA, Ltd., Siemens AG, Becton, Dickinson & Company, Grifols S.A, F. Hoffmann-La Roche AG, Helena Labor, and Axis-Shield.
Key Developments:
In February 2019, Horiba Medical, announced the launch of its new parameter, Yumizen D-Dimer, for its Yumizen G Hemostasis range of instruments developed for diagnosing deep vein thrombosis and pulmonary embolism.
In 2017, Werfen and its subsidiary Instrumentation Laboratory Company announced acquisition of Accriva Diagnostics for expanding its leadership in point of care testing.
In 2016, Siemens Healthineers introduced a new mid-volume coagulation analyser, Sysmex CS-2500 that allows labs to offer quality test results and achieve cost-effective method consolidation.
In 2015, Roche AG announced the launch of new lab-coagulation solution, the cobas t 411 analyzer, which is a lab coagulation system that can be used for low volume routine testing. With this launch, the company increased its portfolio of diagnostic products.
To Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/434
Table of Contents:
- Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations - Market Overview
o Report Description
โข Market Definition and Scope
o Executive Summary
โข Market Snippet By Product Type
โข Market Snippet By Application
โข Market Snippet By Technology
โข Market Snippet By End User
โข Market Snippet By Region
o Coherent Opportunity Map (COM) - Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
โข Drivers
โข Restraints
โข Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis - Global Hemostasis Diagnostics Market, By Product Type, 2021 โ 2028 (US$ Million)
o Introduction
โข Market Share Analysis, 2016 and 2028 (%)
โข Y-o-Y Growth Analysis, 2021 โ 2028
โข Segment Trends
o Reagents & Consumables
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Softwareโs
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Instruments
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million) - Global Hemostasis Diagnostics Market, By Application, 2021 โ 2028 (US$ Million)
o Introduction
โข Market Share Analysis, 2016 and 2028 (%)
โข Y-o-Y Growth Analysis, 2021 โ 2028
โข Segment Trends
o Genomics
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Proteomics
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Diagnostics
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Drug Discovery
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million) - Global Hemostasis Diagnostics Market, By Technology, 2021 โ 2028 (US$ Million)
o Introduction
โข Market Share Analysis, 2016 and 2028 (%)
โข Y-o-Y Growth Analysis, 2021 โ 2028
โข Segment Trends
o Microarrays
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Microfluidics
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million) - Global Hemostasis Diagnostics Market, By End User, 2021 โ 2028 (US$ Million)
o Introduction
โข Market Share Analysis, 2016 and 2028 (%)
โข Y-o-Y Growth Analysis, 2021 โ 2028
โข Segment Trends
o Hospitals
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Diagnostic Labs
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Academic & Research Institutes
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
โข Introduction
โข Market Size and Forecast, and Y-o-Y Growth, 2021 โ 2028, (US$ Million)
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837